Ken Furudate
- Hematology top 5%
- Oncology
- Molecular Biology
- Public Health, Environmental and Occupational Health
- Genetics
- Co-authors
- Wataru KobayashiKosei KubotaKoichi TakahashiFarhad RavandiMarina KonoplevaNicholas J. ShortHagop M. KantarjianMusa Yılmaz
- Topics
- Acute Myeloid Leukemia Research (6 papers)Chronic Myeloid Leukemia Treatments (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)
- Partner nations
- JapanUnited StatesIsrael
In The Last Decade
Ken Furudate
27 papers receiving 309 citations
Peers
Comparison fields: 5 of 71
- Hematology 154
- Oncology 94
- Molecular Biology 85
- Public Health, Environmental and Occupational Health 51
- Genetics 43
Countries citing papers authored by Ken Furudate
This map shows the geographic impact of Ken Furudate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Furudate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Furudate more than expected).
Fields of papers citing papers by Ken Furudate
This network shows the impact of papers produced by Ken Furudate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Furudate. The network helps show where Ken Furudate may publish in the future.
Co-authorship network of co-authors of Ken Furudate
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Furudate. A scholar is included among the top collaborators of Ken Furudate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Furudate. Ken Furudate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 17 | |
| 8 | 45 | |
| 9 | 100 | |
| 10 | 26 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 7 | |
| 14 | 12 | |
| 15 | 1 | |
| 16 | 3 | |
| 17 | 4 | |
| 18 | 33 | |
| 19 | 12 | |
| 20 | 0 |
About Ken Furudate
Ken Furudate is a scholar working on Hematology, Otorhinolaryngology and Genetics, having authored 31 papers that have together received 313 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (154 citations), Otorhinolaryngology (34 citations) and Genetics (43 citations). Ken Furudate has collaborated with scholars based in Japan, United States and Israel. Frequent co-authors include Wataru Kobayashi, Kosei Kubota, Koichi Takahashi, Farhad Ravandi, Marina Konopleva, Nicholas J. Short, Hagop M. Kantarjian, Musa Yılmaz, Tapan M. Kadia and Koji Sasaki. Their work appears in journals such as Blood, Cancer and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.